Logo image of BZUN

BAOZUN INC-SPN ADR (BZUN) Stock Fundamental Analysis

NASDAQ:BZUN - Nasdaq - US06684L1035 - ADR - Currency: USD

2.61  +0.06 (+2.35%)

Premarket: 2.6099 0 (0%)

Fundamental Rating

2

BZUN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 31 industry peers in the Broadline Retail industry. Both the profitability and financial health of BZUN have multiple concerns. BZUN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

BZUN had negative earnings in the past year.
BZUN had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: BZUN reported negative operating cash flow in multiple years.
BZUN Yearly Net Income VS EBIT VS OCF VS FCFBZUN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M -400M 600M -600M

1.2 Ratios

BZUN has a Return On Assets (-2.66%) which is in line with its industry peers.
BZUN has a Return On Equity (-6.79%) which is in line with its industry peers.
Industry RankSector Rank
ROA -2.66%
ROE -6.79%
ROIC N/A
ROA(3y)-3.63%
ROA(5y)-0.57%
ROE(3y)-9.09%
ROE(5y)-1.87%
ROIC(3y)N/A
ROIC(5y)N/A
BZUN Yearly ROA, ROE, ROICBZUN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10 -15

1.3 Margins

The Gross Margin of BZUN (72.66%) is better than 96.77% of its industry peers.
In the last couple of years the Gross Margin of BZUN has grown nicely.
The Profit Margin and Operating Margin are not available for BZUN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 72.66%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.19%
GM growth 5Y3.13%
BZUN Yearly Profit, Operating, Gross MarginsBZUN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

3

2. Health

2.1 Basic Checks

BZUN does not have a ROIC to compare to the WACC, probably because it is not profitable.
BZUN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
BZUN Yearly Shares OutstandingBZUN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M
BZUN Yearly Total Debt VS Total AssetsBZUN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

2.2 Solvency

Based on the Altman-Z score of 1.23, we must say that BZUN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.23, BZUN is doing worse than 64.52% of the companies in the same industry.
BZUN has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
BZUN has a Debt to Equity ratio (0.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 1.23
ROIC/WACCN/A
WACC6.06%
BZUN Yearly LT Debt VS Equity VS FCFBZUN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.94 indicates that BZUN should not have too much problems paying its short term obligations.
BZUN's Current ratio of 1.94 is fine compared to the rest of the industry. BZUN outperforms 64.52% of its industry peers.
BZUN has a Quick Ratio of 1.66. This is a normal value and indicates that BZUN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of BZUN (1.66) is better than 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.94
Quick Ratio 1.66
BZUN Yearly Current Assets VS Current LiabilitesBZUN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.59% over the past year.
EPS 1Y (TTM)34.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.7%

3.2 Future

Based on estimates for the next years, BZUN will show a very strong growth in Earnings Per Share. The EPS will grow by 87.85% on average per year.
The Revenue is expected to grow by 4.45% on average over the next years.
EPS Next Y212.85%
EPS Next 2Y111.57%
EPS Next 3Y108.01%
EPS Next 5Y87.85%
Revenue Next Year4.37%
Revenue Next 2Y4.2%
Revenue Next 3Y4.43%
Revenue Next 5Y4.45%

3.3 Evolution

BZUN Yearly Revenue VS EstimatesBZUN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B 10B
BZUN Yearly EPS VS EstimatesBZUN Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 4 6 8

2

4. Valuation

4.1 Price/Earnings Ratio

BZUN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 23.50, which indicates a rather expensive current valuation of BZUN.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BZUN is on the same level as its industry peers.
BZUN's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 21.20.
Industry RankSector Rank
PE N/A
Fwd PE 23.5
BZUN Price Earnings VS Forward Price EarningsBZUN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BZUN Per share dataBZUN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as BZUN's earnings are expected to grow with 108.01% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y111.57%
EPS Next 3Y108.01%

0

5. Dividend

5.1 Amount

No dividends for BZUN!.
Industry RankSector Rank
Dividend Yield N/A

BAOZUN INC-SPN ADR

NASDAQ:BZUN (4/30/2025, 8:00:02 PM)

Premarket: 2.6099 0 (0%)

2.61

+0.06 (+2.35%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryBroadline Retail
Earnings (Last)03-20 2025-03-20/bmo
Earnings (Next)05-22 2025-05-22
Inst Owners20.2%
Inst Owner Change-0.22%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap152.86M
Analysts82.86
Price Target3.72 (42.53%)
Short Float %6.08%
Short Ratio3.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-22.1%
Min EPS beat(2)-58.25%
Max EPS beat(2)14.05%
EPS beat(4)2
Avg EPS beat(4)-288.83%
Min EPS beat(4)-1178.43%
Max EPS beat(4)67.32%
EPS beat(8)2
Avg EPS beat(8)-181.89%
EPS beat(12)5
Avg EPS beat(12)-231.23%
EPS beat(16)8
Avg EPS beat(16)-159.64%
Revenue beat(2)0
Avg Revenue beat(2)-0.93%
Min Revenue beat(2)-0.94%
Max Revenue beat(2)-0.91%
Revenue beat(4)0
Avg Revenue beat(4)-3.67%
Min Revenue beat(4)-9.83%
Max Revenue beat(4)-0.91%
Revenue beat(8)1
Avg Revenue beat(8)-2.67%
Revenue beat(12)1
Avg Revenue beat(12)-3.24%
Revenue beat(16)4
Avg Revenue beat(16)-2.28%
PT rev (1m)3.34%
PT rev (3m)10.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)-168.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 23.5
P/S 0.13
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 0.32
EV/EBITDA N/A
EPS(TTM)-0.1
EYN/A
EPS(NY)0.11
Fwd EY4.25%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS20.71
BVpS9.63
TBVpS8.17
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.66%
ROE -6.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 72.66%
FCFM N/A
ROA(3y)-3.63%
ROA(5y)-0.57%
ROE(3y)-9.09%
ROE(5y)-1.87%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.19%
GM growth 5Y3.13%
F-ScoreN/A
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.94
Quick Ratio 1.66
Altman-Z 1.23
F-ScoreN/A
WACC6.06%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%61.43%
EPS Next Y212.85%
EPS Next 2Y111.57%
EPS Next 3Y108.01%
EPS Next 5Y87.85%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%7.7%
Revenue Next Year4.37%
Revenue Next 2Y4.2%
Revenue Next 3Y4.43%
Revenue Next 5Y4.45%
EBIT growth 1Y-468.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year247.84%
EBIT Next 3Y80.74%
EBIT Next 5Y51.62%
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A